Marcus Ruscetti, PhD
Research Focus - Harnessing Intrinsic Tumor Suppressor Pathways to Restore Anti-Tumor Immunity
-
Dissecting the transcriptional and epigenetic regulation of a tumor suppressive process known as cellular senescence in different tumor contexts
-
Harnessing the senescence-associated secretory phenotype (SASP) to reengage immune surveillance and overcome immunotherapy resistance in pancreatic cancer
-
Elucidating and targeting genetic mediators of immune escape in prostate cancer metastasis using an innovative mouse modeling approach
-
Uncovering mechanisms of resistance to RAS targeted therapies and senescence and immune surveillance bypass in lung cancer
Representative Publication
Ruscetti M, Morris JP IV, Mezzadra, R et al. Senescence-induced vascular remodeling creates therapeutic vulnerabilities in pancreas cancer. Cell 2020;181(2):424-441.
In the News
Getting Results…
-
Read more
-
UMass Chan BRIDGE Fund commits $2M in six faculty projects
Read more -
PODCAST: Marcus Ruscetti shares his research journey in cancer biology
Read more -
Marcus Ruscetti receives American Cancer Society award for prostate cancer research
Read more -
UMass Cancer Center funds five UMass Chan research projects
Read more